Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies

Hypereosinophilic syndrome (HES) represents a group of blood disorders characterized by an absolute eosinophil count (AEC) > 1.5 × 103/μl in the peripheral blood, which eventually extravasate and cause organ damage. It can be primary or secondary to infections or tumors. The infiltration of eosin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazzari, Chiara, Yacoub, Mona Rita, Campochiaro, Corrado, Bulotta, Alessandra, Palumbo, Diego, Ogliari, Francesca Rita, Dagna, Lorenzo, Marchesi, Silvia, Ponzoni, Maurilio, Gregorc, Vanesa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911301/
https://www.ncbi.nlm.nih.gov/pubmed/36776300
http://dx.doi.org/10.3389/fonc.2023.1079034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911301/
https://www.ncbi.nlm.nih.gov/pubmed/36776300
http://dx.doi.org/10.3389/fonc.2023.1079034

Ejemplares similares